Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity.
about
Omega 6 fatty acids for the primary prevention of cardiovascular diseasePros and cons of CLA consumption: an insight from clinical evidencest-10, c-12 CLA dietary supplementation inhibits atherosclerotic lesion development despite adverse cardiovascular and hepatic metabolic marker profilesFeeding butter with elevated content of trans-10, cis-12 conjugated linoleic acid to lean rats does not impair glucose tolerance or muscle insulin response.Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production.Fat burners: nutrition supplements that increase fat metabolism.Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice.Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health.Flaxseed oil prevents trans-10, cis-12-conjugated linoleic acid-induced insulin resistance in mice.Dietary conjugated linoleic Acid and hepatic steatosis: species-specific effects on liver and adipose lipid metabolism and gene expression.Lipophilic compound-mediated gene expression and implication for intervention in reactive oxygen species (ROS)-related diseases: mini-reviewCross-sectional study of conjugated linoleic acid in adipose tissue and risk of diabetesFeeding butter with elevated content of trans-10, cis-12 conjugated linoleic acid to obese-prone rats impairs glucose and insulin tolerance.Metabolically distinct weight loss by 10,12 CLA and caloric restriction highlight the importance of subcutaneous white adipose tissue for glucose homeostasis in mice.Modulation of PPAR-γ by Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory DiseasesThe body fat-lowering effect of conjugated linoleic acid: a comparison between animal and human studies.Conjugated linoleic acid modulation of risk factors associated with atherosclerosisEffect of conjugated linoleic acid and vitamin E on glycemic control, body composition, and inflammatory markers in overweight type2 diabetics.Conjugated linoleic acid improves glycemic response, lipid profile, and oxidative stress in obese patients with non-alcoholic fatty liver disease: a randomized controlled clinical trial.Conjugated linoleic acids as functional food: an insight into their health benefits.Implication of conjugated linoleic acid (CLA) in human health.Mitochondrial dysfunction as a central event for mechanisms underlying insulin resistance: the roles of long chain fatty acids.Conjugated Linoleic Acid and Postmenopausal Women's Health.Trans-10, cis-12 conjugated linoleic acid antagonizes ligand-dependent PPARgamma activity in primary cultures of human adipocytes.Effects of conjugated linoleic acid/n-3 and resistance training on muscle quality and expression of atrophy-related ubiquitin ligases in middle-aged mice with high-fat dietinduced obesityRosiglitazone Improves Insulin Resistance Mediated by 10,12 Conjugated Linoleic Acid in a Male Mouse Model of Metabolic Syndrome.Effects of high-fat high-sucrose feeding, energy restriction, and trans-10,cis-12 conjugated linoleic acid on visfatin and apelin in hamsters.c9t11-Conjugated linoleic acid-rich oil fails to attenuate wasting in colon-26 tumor-induced late-stage cancer cachexia in male CD2F1 mice.Immunological and metabolic effects of cis-9, trans-11-conjugated linoleic acid in subjects with birch pollen allergy.Opinion of the Scientific Panel on Dietetic products, nutrition and allergies [NDA] related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acidsScientific Opinion on the safety of “conjugated linoleic acid (CLA)-rich oil” (Tonalin® TG 80) as a Novel Food ingredientScientific Opinion on the safety of “conjugated linoleic acid (CLA)-rich oil” (Clarinol®) as a Novel Food ingredientThe effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.
P2860
Q24187758-FC021DB8-3AE6-4384-BA70-F08302A3B913Q26827096-72EEF199-A517-4BA4-B66A-B248B42E5FA2Q27324291-27A4AF44-5422-4DBC-B993-5C2F5B1A1BAEQ33851439-F95812CA-1848-4B74-B06A-F31186E7E011Q34147790-EBB7E6AF-DFC5-4754-9CCA-CF65875065FFQ34219680-8C303741-2A87-4018-B66A-13C143CE54BAQ34249794-1A2E0941-DF30-48AF-BEE3-E210D93A15E9Q34488742-767E967C-8EF3-430E-94A1-DD55C587CFE3Q34810136-E7E83AA3-361C-430C-825E-26728A708B42Q35176821-FE70202C-BEC1-4125-BDA2-527063619219Q35671000-B326695F-030E-4ED5-B75A-2E006C4EC761Q36030446-FE57C78F-096A-4D19-A70B-F1A0CF8C859CQ36105110-7B82E7C6-B302-41E6-BF26-13C127F982D1Q36292968-EAC35328-2E9A-4E1D-95BD-8A28E7865262Q36449677-E6F0C1B7-3682-47BD-AD4D-96C09A112556Q36705132-332C6DC7-CC6E-4BAA-BE69-CE07B7D7B562Q36897274-FDC69A91-1D4A-49D9-970B-0E0860265751Q37053671-CE38C13C-4AB3-4EC0-BBB9-DF3DE9BAF50AQ37307239-99A3E621-A758-4316-8707-071EADF97A16Q37370004-05DF9741-38C4-43EE-B49D-BBB178D92ED4Q37997517-B2D8DA90-076F-4E4A-BEA6-5CF7E6150BBAQ38241510-30B2F3AC-BF19-4DB8-97B3-EF95DBE6D8F4Q38473040-49445FBD-A925-4287-8F01-5104005D32A1Q42141293-130563B8-3A52-4A06-88C7-9FE4362AEFB9Q42378772-CFD0F235-F1C0-42F9-B1B9-13F9FD59FA6BQ42799582-DB011C75-2FF6-4B86-BDA7-8C78DCFBB4E9Q43048272-D6DD163F-36AA-4FE8-BF2F-1ABC08358DCAQ45252295-FE13EF7B-2605-4913-AC77-62CF5DBA9E17Q46826835-104B26FB-C0DC-4BBF-AC41-4D51415F1898Q47143312-517DC10B-B0F1-4B4C-B767-C20E2BFF2A1DQ47148357-CEE8F03E-4C68-41DA-BF60-52BB54BD6C7FQ47148362-A70325B4-D2A7-4E91-990D-93BB938D87F5Q51488012-57BCA1EA-1E01-4736-94EA-ED603144A245
P2860
Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Supplementation with trans10ci ...... impaired insulin sensitivity.
@en
Supplementation with trans10ci ...... impaired insulin sensitivity.
@nl
type
label
Supplementation with trans10ci ...... impaired insulin sensitivity.
@en
Supplementation with trans10ci ...... impaired insulin sensitivity.
@nl
prefLabel
Supplementation with trans10ci ...... impaired insulin sensitivity.
@en
Supplementation with trans10ci ...... impaired insulin sensitivity.
@nl
P2093
P1433
P1476
Supplementation with trans10ci ...... impaired insulin sensitivity.
@en
P2093
P2888
P304
P356
10.1007/S00125-004-1421-8
P50
P577
2004-05-28T00:00:00Z